Christopher P. Lowe - Aug 16, 2021 Form 4 Insider Report for Cortexyme, Inc. (QNCX)

Signature
/s/ Caryn McDowell, Attorney-in-Fact for Christopher Lowe
Stock symbol
QNCX
Transactions as of
Aug 16, 2021
Transactions value $
-$1,980,819
Form type
4
Date filed
8/18/2021, 05:25 PM
Previous filing
Jun 30, 2021
Next filing
Oct 7, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction QNCX Common Stock Options Exercise $49.1K +22K +73.33% $2.23 52K Aug 16, 2021 Direct
transaction QNCX Common Stock Sale -$863K -9.16K -17.61% $94.23 42.8K Aug 16, 2021 Direct F1, F2
transaction QNCX Common Stock Sale -$697K -7.34K -17.12% $95.02 35.5K Aug 16, 2021 Direct F1, F3
transaction QNCX Common Stock Sale -$224K -2.33K -6.56% $96.32 33.2K Aug 16, 2021 Direct F1, F4
transaction QNCX Common Stock Sale -$107K -1.1K -3.32% $97.28 32.1K Aug 16, 2021 Direct F1, F5
transaction QNCX Common Stock Sale -$205K -2.08K -6.48% $98.90* 30K Aug 16, 2021 Direct F1
transaction QNCX Common Stock Options Exercise $66.9K +30K +100% $2.23 60K Aug 17, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction QNCX Stock Option (right to buy) Options Exercise $0 -22K -11.87% $0.00 163K Aug 16, 2021 Common Stock 22K $2.23 Direct F6
transaction QNCX Stock Option (right to buy) Options Exercise $0 -30K -18.37% $0.00 133K Aug 17, 2021 Common Stock 30K $2.23 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.63 to $94.63, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.66 to $95.65, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.68 to $96.62, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.89 to $97.85, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F6 The option vested as to 25% of the shares on November 15, 2019, with the remaining 75% of shares vesting in equal monthly installments beginning on December 15, 2019 and ending on November 15, 2022.